Your browser doesn't support javascript.
loading
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.
Morrow, David A; Velazquez, Eric J; DeVore, Adam D; Prescott, Margaret F; Duffy, Carol I; Gurmu, Yared; McCague, Kevin; Rocha, Ricardo; Braunwald, Eugene.
Afiliação
  • Morrow DA; TIMI Study Group, 75 Francis Street, Boston, MA, USA.
  • Velazquez EJ; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • DeVore AD; Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8056, USA.
  • Prescott MF; Duke Clinical Research Institute, Duke University, 2400 Pratt St, Durham, NC, USA.
  • Duffy CI; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, USA.
  • Gurmu Y; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, USA.
  • McCague K; TIMI Study Group, 75 Francis Street, Boston, MA, USA.
  • Rocha R; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Braunwald E; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, USA.
Eur Heart J ; 40(40): 3345-3352, 2019 10 21.
Article em En | MEDLINE | ID: mdl-31093657

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrazóis / Enalapril / Antagonistas de Receptores de Angiotensina / Aminobutiratos / Insuficiência Cardíaca Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrazóis / Enalapril / Antagonistas de Receptores de Angiotensina / Aminobutiratos / Insuficiência Cardíaca Idioma: En Ano de publicação: 2019 Tipo de documento: Article